How to Buy Argenx Se Stock
Argenx Se
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China.
Argenx Se stock last closed at $645.14, up 2.48% from the previous day, and has increased 71.81% in one year. It has overperformed other stocks in the Biotechnology industry by 1.49 percentage points. Argenx Se stock is currently +82.88% from its 52-week low of $352.77, and -4.88% from its 52-week high of $678.21.
As of Apr 30, 2025, there are 60.76M ARGX shares outstanding. The market capitalization of ARGX is $39.20B. In the last 24 hours, 319,772 ARGX shares were traded.
How to Buy Argenx Se Stock
Wondering how to invest in Argenx Se stock? Here's how.
- Figure out where to buy Argenx Se stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Argenx Se stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Select your payment method and add your details.
- Research Argenx Se stock: The Argenx Se ticker symbol is ARGX. Is Argenx Se stock a good investment? Should you buy shares of ARGX? How do ARGX's underlying business fundamentals look? Do top analysts think Argenx Se is a good buy? Why has ARGX's stock price moved recently? (Hint: Our stock research website can help you understand if ARGX is a good stock to buy).
- Execute your ARGX trade: Decide if you will purchase ARGX shares at the current market price or use a limit order to buy ARGX stock at a particular price.
- Monitor your investment in ARGX: Create a watchlist to keep tabs on your new investment in Argenx Se stock.
Step 1: Figure out where to buy Argenx Se stock
You need an online brokerage account in order to access the NASDAQ market and buy ARGX stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you are able to buy ARGX stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new trading account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have opened your account on the best stock trading app, you need to deposit funds:
Check out the tutorial below if you need help depositing funds into your investment account.
Step 4: Research Argenx Se stock
After you have figured out the best place to buy Argenx Se stock, it's absolutely critical to research their stock before you buy, so you truly wrap your head around the risk as well as the opportunity.
Argenx Se quick stats
Argenx Se Due Diligence Checks
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on ARGX's stock page.
Is ARGX stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge ARGX's true value.
Using relative valuations ratios:
- ARGX could be undervalued based on its P/E ratio of 42.64x, relative to Biotechnology industry P/E ratio of -162.28x
- ARGX may be overvalued based on its P/B ratio of 6.56x, relative to Biotechnology industry P/B ratio of 4.45x
- ARGX may be overvalued based on its PEG ratio of 1.71x
You can access additional valuation analysis on ARGX's stock here.
ARGX Financials at a glance
Pros:
- There are more short-term assets than short-term liabilities on the ARGX balance sheet.
- ARGX profit margin has gone up from -830.4% to 19,159.2% in the past year.
- Total ARGX debt is lower than 5 years ago, relative to shareholder equity.
- ARGX has a low debt to equity ratio of 0.13.
- There are more short-term assets than long-term liabilities on the ARGX balance sheet.
- ARGX has cash burn of 91900000. It has sufficient cash and short-term investments to cover this for at least one year.
- ARGX has $3.67B in cash and short term investments. This is sufficient to cover its annual cash burn of $91.90M.
Is Argenx Se stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 14 Wall Street analysts who give ratings on ARGX, the consensus analyst rating on Argenx Se is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest ARGX Analyst Forecasts
Leland Gershell, a top 5% analyst from Oppenheimer maintains ARGX with a buy rating and raises their ARGX price target from $675.00 to $704.00, on Feb 28, 2025.
Derek Archila, a top 2% analyst from Wells Fargo maintains ARGX with a strong buy rating and raises their ARGX price target from $723.00 to $741.00, on Feb 28, 2025.
Wells Fargo's Derek Archila raised their price target on Argenx Se (NASDAQ: ARGX) by 2.5% from $723 to $741 on 2025/02/28. The analyst maintained their Strong Buy rating on the stock.
Argenx SE reported its Q4 and FY 2024 earnings.
Archila predicted that Vyvgart's sales momentum will carry over into 2025, suggesting a small opportunity for forecasts to be raised.
Additionally, the analyst believes that Argenx's ex-Vyvgart pipeline will benefit from a "couple of modest clinical milestones, which could potentially bring upside."
Earnings Report
Argenx Se reported:
For Q4 2024:
- EPS of $11.79, compared to Q4 2023’s loss of $1.68.
- Revenue of $737M, up 97% Y/Y.
For FY 2024:
- EPS of $12.78, compared to FY 2023’s loss of $5.16.
- Revenue of $2.2B, up 83.5% Y/Y.
Management did not provide EPS and revenue guidance in its guidance.
CEO Tim Van Hauwermeiren commented: "In 2024, we significantly expanded our global patient reach with VYVGART, surpassing 10,000 patients across three indications.
“We are extremely proud of the initial launch efforts of VYVGART Hytrulo in CIDP, where the strength of our data has driven early positive feedback from both patients and physicians.
“This execution has contributed to our position of financial strength as we expect to become a profitable company in 2025.
“We are now more committed than ever to advancing our mission of transforming the autoimmune treatment landscape by investing in innovation and leading with our science.
“Momentum across our business is off to a strong start this year as we continue to execute on our Vision 2030.
“We are focused on maximizing commercial opportunities in gMG and CIDP, including advancing the pre-filled syringe in multiple regions, expanding our label in MG, and deepening relationships within the CIDP community to explore VYVGART Hytrulo’s long-term potential.
“With an expansive pipeline, we are also excited to drive forward 10 Phase 3 and 10 Phase 2 studies in 2025 across efgartigimod, empasiprubart, and ARGX-119, to unlock significant opportunities in high unmet need areas.”
Jason Butler, a top 20% analyst from Citizens Capital Markets maintains ARGX with a buy rating and raises their ARGX price target from $696.00 to $701.00, on Feb 28, 2025.
Joon Lee, a top 2% analyst from Truist Securities reiterates ARGX with a strong buy rating and raises their ARGX price target from $660.00 to $700.00, on Jan 14, 2025.
Allison Bratzel, a top 13% analyst from Piper Sandler maintains ARGX with a strong buy rating and raises their ARGX price target from $620.00 to $725.00, on Jan 7, 2025.
You can dig deeper into what analysts are projecting on the Argenx Se stock forecast page.
ARGX Trading Indicators
ARGX Earnings
Last year, ARGX revenue was $4.73M. Over the last five year, ARGX's revenue has increased by -44.77% per year. This was slower than the Biotechnology industry average of 45.66%.
Learn more about ARGX's earnings and revenue performance here.
What are ARGX executives and large shareholders up to?
Over the past 12 months, executives and large shareholders at ARGX have not bought or sold any shares.
Learn more about who owns ARGX stock here.
Does ARGX provide a stable income stream?
No, Argenx Se doesn't provide an income stream by paying out dividends.
What others are saying about ARGX
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your ARGX trade
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally fine. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given price, place a limit order.
Click the Open Trade button and your broker will place the order.
If you require more assistance buying stocks on eToro, watch the how to video below:
Step 6: Monitor your investment in ARGX
Now that you own some ARGX stock, you'll want to keep up with your stock purchase.
Start a watchlist to track your ARGX stock.
ARGX Feed
How to Buy Stock in Argenx Se
To summarize, here are the 6 steps to buy stock in Argenx Se:
- Figure out where to buy Argenx Se stock
- Create your brokerage account
- Deposit funds into your investment account
- Research Argenx Se stock
- Execute your ARGX trade
- Monitor your investment in ARGX
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to track your new investment in Argenx Se, get started below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.